Prenatal substance abuse: Short- and long-term effects on the exposed fetus

Pediatrics

Volumn 131, Issue 3, 2013, Pages

  Behnke, Marylou ^a   Smith, Vincent C ^a  

^a Committee on Fetus and Newborn ^*  (United States)

Author keywords

Alcohol; Cocaine; Growth and development; Marijuana; Methamphetamine; Nicotine; Prenatal drug exposure

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; ALCOHOL; CANNABIS; COCAINE; ENDORPHIN; GLUTAMATE RECEPTOR; METHAMPHETAMINE; NEUROTRANSMITTER; NICOTINE; NICOTINIC RECEPTOR; OPIATE;

ADAPTIVE BEHAVIOR; ADOLESCENT; ADULT; ARTICLE; COGNITION; CONGENITAL MALFORMATION; CRIMINAL BEHAVIOR; DOPAMINERGIC ACTIVITY; DRUG USE; FETAL ALCOHOL SYNDROME; FETUS GROWTH; HEALTH HAZARD; HUMAN; LIMBIC SYSTEM; PEDIATRICS; PERINATAL PERIOD; POSTNATAL GROWTH; PREGNANT WOMAN; PRENATAL CARE; PRENATAL DRUG EXPOSURE; PRENATAL EXPOSURE; PRENATAL PERIOD; PRENATAL SUBSTANCE ABUSE; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RECOGNITION; SOCIAL BEHAVIOR; SUBSTANCE ABUSE;

FEMALE; FETAL DEVELOPMENT; HUMANS; INFANT, NEWBORN; NEONATAL ABSTINENCE SYNDROME; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RESEARCH REPORT; STREET DRUGS; SUBSTANCE-RELATED DISORDERS; TIME FACTORS;

EID: 84874642999     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2012-3931     Document Type: Article

References (277)

1. Becker RF, Little CR, King JE. Experimental studies on nicotine absorption in rats during pregnancy. 3. Effect of subcutaneous injection of small chronic doses upon mother, fetus, and neonate. Am J Obstet Gynecol. 1968;100(7):957-968
2. Jones KL, Smith DW. Recognition of the fetal alcohol syndrome in early infancy. Lancet. 1973;302(7836):999-1001
3. Jones KL, Smith DW, Ulleland CN, Streissguth P. Pattern of malformation in offspring of chronic alcoholic mothers. Lancet. 1973;1 (7815):1267-1271
4. Finnegan LP. Pathophysiological and behavioural effects of the transplacental transfer of narcotic drugs to the foetuses and neonates of narcotic-dependent mothers. Bull Narc. 1979;31(3-4):1-58
5. Chasnoff IJ, Burns WJ, Schnoll SH, Burns KA. Cocaine use in pregnancy. N Engl J Med. 1985;313(11):666-669
6. Oro AS, Dixon SD. Perinatal cocaine and methamphetamine exposure: maternal and neonatal correlates. J Pediatr. 1987;111(4):571-578
7. Fried PA. Postnatal consequences of maternal marijuana use in humans. Ann N Y Acad Sci. 1989;562:123-132
8. Eyler FD, Behnke M, Wobie K, Garvan CW, Tebbett I. Relative ability of biologic specimens and interviews to detect prenatal cocaine use. Neurotoxicol Teratol. 2005;27(4):677-687
9. Harrell AV. Validation of self-report: the research record. NIDA Res Monogr. 1985;57:12-21
10. Maisto SA, McKay JR, Connors GJ. Selfreport issues in substance abuse: state of the art and future directions. Behav Assess. 1990;12(1):117-134
11. Day NL, Wagener DK, Taylor PM. Measurement of substance use during pregnancy: methodologic issues. NIDA Res Monogr. 1985;59:36-47
12. Magura S, Moses B. Assessing Risk and Measuring Change in Families: The Family Risk Scales. Washington, DC: Child Welfare League of America; 1987
13. Jacobson SW, Chiodo LM, Sokol RJ, Jacobson JL. Validity of maternal report of prenatal alcohol, cocaine, and smoking in relation to neurobehavioral outcome. Pediatrics. 2002;109(5):815-825
14. Kwong TC, Shearer D. Detection of drug use during pregnancy. Obstet Gynecol Clin North Am. 1998;25(1):43-64
15. Lee MJ. Marihuana and tobacco use in pregnancy. Obstet Gynecol Clin North Am. 1998;25(1):65-83
16. Lozano J, García-Algar O, Vall O, de la Torre R, Scaravelli G, Pichini S. Biological matrices for the evaluation of in utero exposure to drugs of abuse. Ther Drug Monit. 2007;29(6):711-734
17. Chiu HT, Isaac Wu HD, Kuo HW. The relationship between self-reported tobacco exposure and cotinines in urine and blood for pregnant women. Sci Total Environ. 2008;406(1-2):331-336
18. Lester BM, ElSohly M, Wright LL, et al. The Maternal Lifestyle Study: drug use by meconium toxicology and maternal selfreport. Pediatrics. 2001;107(2):309-317
19. Casanova OQ, Lombardero N, Behnke M, Eyler FD, Conlon M, Bertholf RL. Detection of cocaine exposure in the neonate. Analyses of urine, meconium, and amniotic fluid from mothers and infants exposed to cocaine. Arch Pathol Lab Med. 1994;118(10):988-993
20. Köhler E, Avenarius S, Rabsilber A, Gerloff C, Jorch G. Assessment of prenatal tobacco smoke exposure by determining nicotine and its metabolites in meconium. Hum Exp Toxicol. 2007;26(6):535-544
21. Bailey DN. Drug screening in an unconventional matrix: hair analysis. [editorial; comment] JAMA. 1989;262(23):3331
22. Joseph RE, Jr, Su TP, Cone EJ. In vitro binding studies of drugs to hair: influence of melanin and lipids on cocaine binding to Caucasoid and Africoid hair. J Anal Toxicol. 1996;20(6):338-344
23. Jurado C, Kintz P, Menéndez M, Repetto M. Influence of the cosmetic treatment of hair on drug testing. Int J Legal Med. 1997;110(3):159-163
24. Henderson GL, Harkey MR, Zhou C, Jones RT, Jacob P III. Incorporation of isotopically labeled cocaine into human hair: race as a factor. J Anal Toxicol. 1998;22(2): 156-165
25. Jacqz-Aigrain E, Zhang D, Maillard G, Luton D, André J, Oury JF. Maternal smoking during pregnancy and nicotine and cotinine concentrations in maternal and neonatal hair. BJOG. 2002;109(8):909-911
26. Winecker RE, Goldberger BA, Tebbett IR, et al. Detection of cocaine and its metabolites in breast milk. J Forensic Sci. 2001;46(5):1221-1223
27. Montgomery D, Plate C, Alder SC, Jones M, Jones J, Christensen RD. Testing for fetal exposure to illicit drugs using umbilical cord tissue vs meconium. J Perinatol. 2006;26(1):11-14
28. Hansen RL, Evans AT, Gillogley KM, Hughes CS, Krener PG. Perinatal toxicology screening. J Perinatol. 1992;12(3):220-224
29. Behnke M, Eyler FD, Conlon M, Woods NS, Casanova OQ. Multiple risk factors do not identify cocaine use in rural obstetrical patients. Neurotoxicol Teratol. 1994;16(5): 479-484
30. Ellsworth MA, Stevens TP, D'Angio CT. Infant race affects application of clinical guidelines when screening for drugs of abuse in newborns. Pediatrics. 2010;125 (6). Available at: www.pediatrics.org/cgi/content/full/125/6/e1379
31. Behnke M, Eyler FD, Conlon M, Casanova OQ, Woods NS. How fetal cocaine exposure increases neonatal hospital costs. Pediatrics. 1997;99(2):204-208
32. Stahl SM. Essential Psychopharmacology: Neuroscience Basis and Practical Application, 2nd ed. New York, NY: Cambridge Press; 2000
33. Bauer CR, Shankaran S, Bada HS, et al. The Maternal Lifestyle Study: drug exposure during pregnancy and short-term maternal outcomes. Am J Obstet Gynecol. 2002;186(3):487-495
34. Mosier HD, Jr, Jansons RA. Distribution and fate of nicotine in the rat fetus. Teratology. 1972;6(3):303-311
35. Luck W, Nau H, Hansen R, Steldinger R. Extent of nicotine and cotinine transfer to the human fetus, placenta and amniotic fluid of smoking mothers. Dev Pharmacol Ther. 1985;8(6):384-395
36. Koren G. Fetal toxicology of environmental tobacco smoke. Curr Opin Pediatr. 1995;7 (2):128-131
37. Lehtovirta P, Forss M. The acute effect of smoking on intervillous blood flow of the placenta. Br J Obstet Gynaecol. 1978;85 (10):729-731
38. Ahlsten G, Ewald U, Tuvemo T. Maternal smoking reduces prostacyclin formation in human umbilical arteries. A study on strictly selected pregnancies. Acta Obstet Gynecol Scand. 1986;65(6):645-649
39. Joschko MA, Dreosti IE, Tulsi RS. The teratogenic effects of nicotine in vitro in rats: a light and electron microscope study. Neurotoxicol Teratol. 1991;13(3):307-316
40. Lichtensteiger W, Schlumpf M. Prenatal nicotine exposure: biochemical and neuroendocrine bases of behavioral dysfunction. Dev Brain Dysfunc. 1993;6(4-5): 279-304
41. Seidler FJ, Albright ES, Lappi SE, Slotkin TA. In search of a mechanism for receptor-mediated neurobehavioral teratogenesis by nicotine: catecholamine release by nicotine in immature rat brain regions. Brain Res Dev Brain Res. 1994;82 (1-2):1-8
42. Slotkin TA. Fetal nicotine or cocaine exposure: which one is worse? J Pharmacol Exp Ther. 1998;285(3):931-945
43. Hellström-Lindahl E, Seiger A, Kjaeldgaard A, Nordberg A. Nicotine-induced alterations in the expression of nicotinic receptors in primary cultures from human prenatal brain. Neuroscience. 2001;105(3):527-534
44. Holsclaw DS, Jr, Topham AL. The effects of smoking on fetal, neonatal, and childhood development. Pediatr Ann. 1978;7(3):201-222
45. Abel EL. Smoking and pregnancy. J Psychoactive Drugs. 1984;16(4):327-338
46. Hazelhoff Roelfzema W, Roelofsen AM, Copius Peereboom-Stegeman JH. Light microscopic aspects of the rat placenta after chronic cadmium administration. Sci Total Environ. 1985;42(1-2):181-184
47. Aaronson LS, Macnee CL. Tobacco, alcohol, and caffeine use during pregnancy. J Obstet Gynecol Neonatal Nurs. 1989;18 (4):279-287
48. Floyd RL, Zahniser SC, Gunter EP, Kendrick JS. Smoking during pregnancy: prevalence, effects, and intervention strategies. Birth. 1991;18(1):48-53
49. Brien JF, Clarke DW, Smith GN, Richardson B, Patrick J. Disposition of acute, multipledose ethanol in the near-term pregnant ewe. Am J Obstet Gynecol. 1987;157(1): 204-211
50. Szeto HH. Kinetics of drug transfer to the fetus. Clin Obstet Gynecol. 1993;36(2):246-254
51. Sulik KK, Johnston MC, Webb MA. Fetal alcohol syndrome: embryogenesis in a mouse model. Science. 1981;214(4523): 936-938
52. West JR, Hodges CA, Black AC Jr. Prenatal exposure to ethanol alters the organization of hippocampal mossy fibers in rats. Science. 1981;211(4485):957- 959
53. Kennedy LA. The pathogenesis of brain abnormalities in the fetal alcohol syndrome: an integrating hypothesis. Teratology. 1984;29(3):363-368
54. Fisher SE. Selective fetal malnutrition: the fetal alcohol syndrome. J Am Coll Nutr. 1988;7(2):101-106
55. Hoff SF. Synaptogenesis in the hippocampal dentate gyrus: effects of in utero ethanol exposure. Brain Res Bull. 1988;21 (1):47-54
56. Clarren SK, Astley SJ, Bowden DM, et al. Neuroanatomic and neurochemical abnormalities in nonhuman primate infants exposed to weekly doses of ethanol during gestation. Alcohol Clin Exp Res. 1990;14(5):674-683
57. Druse MJ, Tajuddin N, Kuo A, Connerty M. Effects of in utero ethanol exposure on the developing dopaminergic system in rats. J Neurosci Res. 1990;27(2):233-240
58. Jollie WP. Effects of sustained dietary ethanol on the ultrastructure of the visceral yolk-sac placenta of the rat. Teratology. 1990;42(5):541-552
59. Michaelis EK. Fetal alcohol exposure: cellular toxicity and molecular events involved in toxicity. Alcohol Clin Exp Res. 1990;14(6):819-826
60. Schenker S, Becker HC, Randall CL, Phillips DK, Baskin GS, Henderson GI. Fetal alcohol syndrome: current status of pathogenesis. Alcohol Clin Exp Res. 1990;14(5):635-647
61. West JR, Goodlett CR, Bonthius DJ, Hamre KM, Marcussen BL. Cell population depletion associated with fetal alcohol brain damage: mechanisms of BAC-dependent cell loss. Alcohol Clin Exp Res. 1990;14 (6):813-818
62. Wigal SB, Amsel A, Wilcox RE. Fetal ethanol exposure diminishes hippocampal betaadrenergic receptor density while sparing muscarinic receptors during development. Brain Res Dev Brain Res. 1990;55(2):161-169
63. Brien JF, Smith GN. Effects of alcohol (ethanol) on the fetus. J Dev Physiol. 1991;15(1):21-32
64. Ledig M, Megias-Megias L, Tholey G. Maternal alcohol exposure before and during pregnancy: effect on development of neurons and glial cells in culture. Alcohol Alcohol. 1991;26(2):169-176
65. Miller MW, Nowakowski RS. Effect of prenatal exposure to ethanol on the cell cycle kinetics and growth fraction in the proliferative zones of fetal rat cerebral cortex. Alcohol Clin Exp Res. 1991;15(2): 229-232
66. Smith GN, Patrick J, Sinervo KR, Brien JF. Effects of ethanol exposure on the embryo-fetus: experimental considerations, mechanisms, and the role of prostaglandins. Can J Physiol Pharmacol. 1991;69(5):550-569
67. Gressens P, Lammens M, Picard JJ, Evrard P. Ethanol-induced disturbances of gliogenesis and neuronogenesis in the developing murine brain: an in vitro and in vivo immunohistochemical and ultrastructural study. Alcohol Alcohol. 1992;27 (3):219-226
68. Kotch LE, Sulik KK. Experimental fetal alcohol syndrome: proposed pathogenic basis for a variety of associated facial and brain anomalies. Am J Med Genet. 1992;44 (2):168-176
69. Miller MW, Robertson S. Prenatal exposure to ethanol alters the postnatal development and transformation of radial glia to astrocytes in the cortex. J Comp Neurol. 1993;337(2):253-266
70. Bailey JR, Cunny HC, Paule MG, Slikker W Jr. Fetal disposition of delta 9-tetrahydrocannabinol (THC) during late pregnancy in the rhesus monkey. Toxicol Appl Pharmacol. 1987;90(2):315-321
71. Abrams RM, Cook CE, Davis KH, Niederreither K, Jaeger MJ, Szeto HH. Plasma delta-9-tetrahydrocannabinol in pregnant sheep and fetus after inhalation of smoke from a marijuana cigarette. Alcohol Drug Res. 1985-1986;6(5):361-369
72. Hutchings DE, Martin BR, Gamagaris Z, Miller N, Fico T. Plasma concentrations of delta-9-tetrahydrocannabinol in dams and fetuses following acute or multiple prenatal dosing in rats. Life Sci. 1989;44 (11):697-701
73. Murthy NV, Melville GN, Wynter HH. Contractile responses of uterine smooth muscle to acetylcholine and marihuana extract. Int J Gynaecol Obstet. 1983;21(3):223-226
74. Dalterio SL. Cannabinoid exposure: effects on development. Neurobehav Toxicol Teratol. 1986;8(4):345-352
75. Fisher SE, Atkinson M, Chang B. Effect of delta-9-tetrahydrocannabinol on the in vitro uptake of alpha-amino isobutyric acid by term human placental slices. Pediatr Res. 1987;21(1):104-107
76. Walters DE, Carr LA. Changes in brain catecholamine mechanisms following perinatal exposure to marihuana. Pharmacol Biochem Behav. 1986;25(4):763-768
77. Morgan B, Brake SC, Hutchings DE, Miller N, Gamagaris Z. Delta-9-tetrahydrocannabinol during pregnancy in the rat: effects on development of RNA, DNA, and protein in offspring brain. Pharmacol Biochem Behav. 1988;31(2):365-369
78. Walters DE, Carr LA. Perinatal exposure to cannabinoids alters neurochemical development in rat brain. Pharmacol Biochem Behav. 1988;29(1):213-216
79. Rodríguez de Fonseca F, Cebeira M, Fernández-Ruiz JJ, Navarro M, Ramos JA. Effects of preand perinatal exposure to hashish extracts on the ontogeny of brain dopaminergic neurons. Neuroscience. 1991;43(2-3):713-723
80. Chiriboga CA. Fetal alcohol and drug effects. Neurologist. 2003;9(6):267-279
81. Gerdin E, Rane A, Lindberg B. Transplacental transfer of morphine in man. J Perinat Med. 1990;18(4):305-312
82. Zagon IS, McLaughlin PJ, Weaver DJ, Zagon E. Opiates, endorphins and the developing organism: a comprehensive bibliography. Neurosci Biobehav Rev. 1982;6(4):439-479
83. Lee CC, Chiang CN. Maternal-fetal transfer of abused substances: pharmacokinetic and pharmacodynamic data. NIDA Res Monogr. 1985;60:110-147
84. Wang C, Pasulka P, Perry B, Pizzi WJ, Schnoll SH. Effect of perinatal exposure to methadone on brain opioid and alpha 2-adrenergic receptors. Neurobehav Toxicol Teratol. 1986;8(4):399-402
85. Hammer RP, Jr, Ricalde AA, Seatriz JV. Effects of opiates on brain development. Neurotoxicology. 1989;10(3):475-483
86. Ricalde AA, Hammer RP Jr. Perinatal opiate treatment delays growth of cortical dendrites. Neurosci Lett. 1990;115(2-3):137-143
87. Hauser KF, Stiene-Martin A. Characterization of opioid-dependent glial development in dissociated and organotypic cultures of mouse central nervous system: critical periods and target specificity. Brain Res Dev Brain Res. 1991;62(2):245-255
88. Zagon IS, McLaughlin PJ. The perinatal opioid syndrome: laboratory findings and clinical implications. In: Sonderegger TB, ed. Perinatal Substance Abuse: Research Findings and Clinical Implications. Baltimore, MD: Johns Hopkins University Press; 1992:207-223
89. Malanga CJ, III, Kosofsky BE. Mechanisms of action of drugs of abuse on the developing fetal brain. Clin Perinatol. 1999;26(1):17-37, v-vi
90. Mayes LC. Neurobiology of prenatal cocaine exposure effect on developing monoamine systems. Infant Ment Health J. 1994;15(2):121-133
91. Dow-Edwards DL. Developmental toxicity of cocaine: mechanisms of action. In: Lewis M, Bendersky M, eds. Mothers, Babies, and Cocaine: The Role of Toxins in Development. Hillsdale, NJ: Lawrence Erlbaum Associates Inc; 1995:5-17
92. Levitt P, Harvey JA, Friedman E, Simansky K, Murphy EH. New evidence for neurotransmitter influences on brain development. Trends Neurosci. 1997;20(6): 269-274
93. Whitaker-Azmitia PM. Role of the neurotrophic properties of serotonin in the delay of brain maturation induced by cocaine. Ann N Y Acad Sci. 1998;846:158-164
94. Harvey JA. Cocaine effects on the developing brain: current status. Neurosci Biobehav Rev. 2004;27(8):751-764
95. Lauder JM. Discussion: neuroteratology of cocaine relationship to developing monoamine systems. NIDA Res Monogr. 1991;114:233-247
96. Woods JR Jr. Adverse consequences of prenatal illicit drug exposure. Curr Opin Obstet Gynecol. 1996;8(6):403-411
97. Mayes LC. Developing brain and in utero cocaine exposure: effects on neural ontogeny. Dev Psychopathol. 1999;11(4):685-714
98. Stanwood GD, Levitt P. Drug exposure early in life: functional repercussions of changing neuropharmacology during sensitive periods of brain development. Curr Opin Pharmacol. 2004;4(1):65-71
99. Burchfield DJ, Lucas VW, Abrams RM, Miller RL, DeVane CL. Disposition and pharmacodynamics of methamphetamine in pregnant sheep. JAMA. 1991;265(15): 1968-1973
100. Won L, Bubula N, McCoy H, Heller A. Methamphetamine concentrations in fetal and maternal brain following prenatal exposure. Neurotoxicol Teratol. 2001;23(4): 349-354
101. Golub M, Costa L, Crofton K, et al. NTP-CERHR Expert Panel Report on the reproductive and developmental toxicity of amphetamine and methamphetamine. Birth Defects Res B Dev Reprod Toxicol. 2005;74(6):471-584
102. Cui C, Sakata-Haga H, Ohta K, et al. Histological brain alterations following prenatal methamphetamine exposure in rats. Congenit Anom (Kyoto). 2006;46(4):180-187
103. Simpson WJ. A preliminary report on cigarette smoking and the incidence of prematurity. Am J Obstet Gynecol. 1957;73 (4):807-815
104. Yerushalmy J. The relationship of parents' cigarette smoking to outcome of pregnancy-implications as to the problem of inferring causation from observed associations. Am J Epidemiol. 1971;93(6): 443-456
105. Persson PH, Grennert L, Gennser G, Kullander S. A study of smoking and pregnancy with special references to fetal growth. Acta Obstet Gynecol Scand Suppl. 1978;78(S78):33-39
106. Olsen J. Cigarette smoking in pregnancy and fetal growth. Does the type of tobacco play a role? Int J Epidemiol. 1992;21(2): 279-284
107. Zarén B, Lindmark G, Gebre-Medhin M. Maternal smoking and body composition of the newborn. Acta Paediatr. 1996;85(2): 213-219
108. Hoff C, Wertelecki W, Blackburn WR, Mendenhall H, Wiseman H, Stumpe A. Trend associations of smoking with maternal, fetal, and neonatal morbidity. Obstet Gynecol. 1986;68(3):317-321
109. Day N, Cornelius M, Goldschmidt L, Richardson G, Robles N, Taylor P. The effects of prenatal tobacco and marijuana use on offspring growth from birth through 3 years of age. Neurotoxicol Teratol. 1992;14(6):407-414
110. Barnett E. Race differences in the proportion of low birth weight attributable to maternal cigarette smoking in a lowincome population. Am J Health Promot. 1995;10(2):105-110
111. Lightwood JM, Phibbs CS, Glantz SA. Shortterm health and economic benefits of smoking cessation: low birth weight. Pediatrics. 1999;104(6):1312-1320
112. DiFranza JR, Aligne CA, Weitzman M. Prenatal and postnatal environmental tobacco smoke exposure and children's health. Pediatrics. 2004;113(suppl 4): 1007-1015
113. Fried PA, Watkinson B, Gray R. Growth from birth to early adolescence in offspring prenatally exposed to cigarettes and marijuana. Neurotoxicol Teratol. 1999;21(5):513-525
114. Fenercioglu AK, Tamer I, Karatekin G, Nuhoglu A. Impaired postnatal growth of infants prenatally exposed to cigarette smoking. Tohoku J Exp Med. 2009;218(3): 221-228
115. Mills JL, Graubard BI, Harley EE, Rhoads GG, Berendes HW. Maternal alcohol consumption and birth weight. How much drinking during pregnancy is safe? JAMA. 1984;252(14):1875-1879
116. Streissguth AP, Martin DC, Martin JC, Barr HM. The Seattle longitudinal prospective study on alcohol and pregnancy. Neurobehav Toxicol Teratol. 1981;3(2):223-233
117. Fried PA, O'Connell CM. A comparison of the effects of prenatal exposure to tobacco, alcohol, cannabis and caffeine on birth size and subsequent growth. Neurotoxicol Teratol. 1987;9(2):79-85
118. Greene T, Ernhart CB, Sokol RJ, et al. Prenatal alcohol exposure and preschool physical growth: a longitudinal analysis. Alcohol Clin Exp Res. 1991;15(6):905-913
119. Jacobson JL, Jacobson SW, Sokol RJ. Effects of prenatal exposure to alcohol, smoking, and illicit drugs on postpartum somatic growth. Alcohol Clin Exp Res. 1994;18(2):317-323
120. Fried PA. Marijuana use during pregnancy: consequences for the offspring. Semin Perinatol. 1991;15(4):280-287
121. English DR, Hulse GK, Milne E, Holman CD, Bower CI. Maternal cannabis use and birth weight: a meta-analysis. Addiction. 1997;92(11):1553-1560
122. Eyler FD, Behnke M, Conlon M, Woods NS, Wobie K. Birth outcome from a prospective, matched study of prenatal crack/cocaine use: I. Interactive and dose effects on health and growth. Pediatrics. 1998;101(2):229-237
123. Hulse GK, Milne E, English DR, Holman CD. The relationship between maternal use of heroin and methadone and infant birth weight. Addiction. 1997;92(11):1571-1579
124. Bada HS, Das A, Bauer CR, et al. Gestational cocaine exposure and intrauterine growth: maternal lifestyle study. Obstet Gynecol. 2002;100(5 pt 1):916-924
125. Chouteau M, Namerow PB, Leppert P. The effect of cocaine abuse on birth weight and gestational age. Obstet Gynecol. 1988;72(3 pt 1):351-354
126. Amaro H, Zuckerman B, Cabral H. Drug use among adolescent mothers: profile of risk. Pediatrics. 1989;84(1):144-151
127. Zuckerman B, Frank DA, Hingson R, et al. Effects of maternal marijuana and cocaine use on fetal growth. N Engl J Med. 1989;320(12):762-768
128. Zuckerman B, Frank DA. Prenatal cocaine exposure: nine years later. [editorial; comment] J Pediatr. 1994;124(5 pt 1):731-733
129. Richardson GA. Prenatal cocaine exposure. A longitudinal study of development. Ann N Y Acad Sci. 1998;846:144-152
130. Bauer CR, Langer JC, Shankaran S, et al. Acute neonatal effects of cocaine exposure during pregnancy. Arch Pediatr Adolesc Med. 2005;159(9):824-834
131. Little BB, Snell LM, Gilstrap LC III. Methamphetamine abuse during pregnancy: outcome and fetal effects. Obstet Gynecol. 1988;72(4):541-544
132. Nguyen D, Smith LM, Lagasse LL, et al. Intrauterine growth of infants exposed to prenatal methamphetamine: results from the infant development, environment, and lifestyle study. J Pediatr. 2010;157(2):337-339
133. Bauer CR. Perinatal effects of prenatal drug exposure. Neonatal aspects. Clin Perinatol. 1999;26(1):87-106
134. Cornelius MD, Day NL. The effects of tobacco use during and after pregnancy on exposed children. Alcohol Res Health. 2000;24(4):242-249
135. Nordstrom-Klee B, Delaney-Black V, Covington C, Ager J, Sokol R. Growth from birth onwards of children prenatally exposed to drugs: a literature review. Neurotoxicol Teratol. 2002;24(4):481-488
136. Wyszynski DF, Duffy DL, Beaty TH. Maternal cigarette smoking and oral clefts: a metaanalysis. Cleft Palate Craniofac J. 1997;34 (3):206-210
137. Wyszynski DF, Wu T. Use of US birth certificate data to estimate the risk of maternal cigarette smoking for oral clefting. Cleft Palate Craniofac J. 2002;39(2):188-192
138. Lammer EJ, Shaw GM, Iovannisci DM, Van Waes J, Finnell RH. Maternal smoking and the risk of orofacial clefts: Susceptibility with NAT1 and NAT2 polymorphisms. Epidemiology. 2004;15(2):150-156
139. Little J, Cardy A, Arslan MT, Gilmour M, Mossey PA; United Kingdom-based casecontrol study. Smoking and orofacial clefts: a United Kingdom-based casecontrol study. Cleft Palate Craniofac J. 2004;41(4):381-386
140. Little J, Cardy A, Munger RG. Tobacco smoking and oral clefts: a meta-analysis. Bull World Health Organ. 2004;82(3):213-218
141. American Academy of Pediatrics, Committee on Substance Abuse and Committee on Children With Disabilities. Fetal alcohol syndrome and alcohol-related neurodevelopmental disorders. Pediatrics. 2000;106(2 pt 1):358-361
142. Astley SJ, Clarren SK, Little RE, Sampson PD, Daling JR. Analysis of facial shape in children gestationally exposed to marijuana, alcohol, and/or cocaine. Pediatrics. 1992;89(1):67-77
143. Behnke M, Eyler FD, Garvan CW, Wobie K. The search for congenital malformations in newborns with fetal cocaine exposure. Pediatrics. 2001;107(5). Available at: www.pediatrics.org/cgi/content/full/107/5/e74
144. Law KL, Stroud LR, LaGasse LL, Niaura R, Liu J, Lester BM. Smoking during pregnancy and newborn neurobehavior. Pediatrics. 2003;111(6 pt 1):1318-1323
145. Godding V, Bonnier C, Fiasse L, et al. Does in utero exposure to heavy maternal smoking induce nicotine withdrawal symptoms in neonates? Pediatr Res. 2004;55(4):645-651
146. Pierog S, Chandavasu O, Wexler I. Withdrawal symptoms in infants with the fetal alcohol syndrome. J Pediatr. 1977;90(4): 630-633
147. Fried PA, Makin JE. Neonatal behavioural correlates of prenatal exposure to marihuana, cigarettes and alcohol in a low risk population. Neurotoxicol Teratol. 1987;9(1):1-7
148. Finnegan LP, Connaughton JF, Jr, Kron RE, Emich JP. Neonatal abstinence syndrome: assessment and management. Addict Dis. 1975;2(1-2):141-158
149. Chasnoff IJ, Hatcher R, Burns WJ. Polydrugand methadone-addicted newborns: a continuum of impairment? Pediatrics. 1982;70(2): 210-213
150. Fischer G, Johnson RE, Eder H, et al. Treatment of opioid-dependent pregnant women with buprenorphine. Addiction. 2000;95(2):239-244
151. Johnson RE, Jones HE, Fischer G. Use of buprenorphine in pregnancy: patient management and effects on the neonate. Drug Alcohol Depend. 2003;70(suppl 2):S87-S101
152. Jones HE, Kaltenbach K, Heil SH, et al. Neonatal abstinence syndrome after methadone or buprenorphine exposure. N Engl J Med. 2010;363(24):2320-2331
153. Eyler FD, Behnke M, Garvan CW, Woods NS, Wobie K, Conlon M. Newborn evaluations of toxicity and withdrawal related to prenatal cocaine exposure. Neurotoxicol Teratol. 2001;23(5):399-411
154. Smith L, Yonekura ML, Wallace T, Berman N, Kuo J, Berkowitz C. Effects of prenatal methamphetamine exposure on fetal growth and drug withdrawal symptoms in infants born at term. J Dev Behav Pediatr. 2003;24(1):17-23
155. Hudak ML, Tan RC; American Academy of Pediatrics, Committee on Drugs, Committee on Fetus and Newborn. Clinical report: neonatal drug withdrawal. Pediatrics. 1998;101(6):1079-1088
156. Picone TA, Allen LH, Olsen PN, Ferris ME. Pregnancy outcome in North American women. II. Effects of diet, cigarette smoking, stress, and weight gain on placentas, and on neonatal physical and behavioral characteristics. Am J Clin Nutr. 1982;36(6):1214-1224
157. Dempsey DA, Hajnal BL, Partridge JC, et al. Tone abnormalities are associated with maternal cigarette smoking during pregnancy in in utero cocaine-exposed infants. Pediatrics. 2000;106(1 pt 1):79-85
158. Streissguth AP, Barr HM, Martin DC. Maternal alcohol use and neonatal habituation assessed with the Brazelton scale. Child Dev. 1983;54(5):1109-1118
159. Brazelton TB. Neonatal Behavioral Assessment Scale, 2nd ed. Philadelphia, PA: JB Lippincott Co; 1984
160. Eyler FD, Behnke M. Early development of infants exposed to drugs prenatally. Clin Perinatol. 1999;26(1):107-150, vii
161. Smith LM, Lagasse LL, Derauf C, et al. Prenatal methamphetamine use and neonatal neurobehavioral outcome. Neurotoxicol Teratol. 2008;30(1):20-28
162. Howard CR, Lawrence RA. Breast-feeding and drug exposure. Obstet Gynecol Clin North Am. 1998;25(1):195-217
163. Cobrinik RW, Hood RT, Jr, Chusid E. The effect of maternal narcotic addiction on the newborn infant; review of literature and report of 22 cases. Pediatrics. 1959;24(2):288-304
164. Perez-Reyes M, Wall ME. Presence of delta9-tetrahydrocannabinol in human milk. N Engl J Med. 1982;307(13):819-820
165. Steiner E, Villén T, Hallberg M, Rane A. Amphetamine secretion in breast milk. Eur J Clin Pharmacol. 1984;27(1):123-124
166. Chasnoff IJ, Lewis DE, Squires L. Cocaine intoxication in a breast-fed infant. Pediatrics. 1987;80(6):836-838
167. Ferguson BB, Wilson DJ, Schaffner W. Determination of nicotine concentrations in human milk. Am J Dis Child. 1976;130(8): 837-839
168. Steldinger R, Luck W, Nau H. Half lives of nicotine in milk of smoking mothers: implications for nursing. J Perinat Med. 1988;16(3):261-262
169. Luck W, Nau H. Nicotine and cotinine concentrations in serum and urine of infants exposed via passive smoking or milk from smoking mothers. J Pediatr. 1985;107(5):816-820
170. Schwartz-Bickenbach D, Schulte-Hobein B, Abt S, Plum C, Nau H. Smoking and passive smoking during pregnancy and early infancy: effects on birth weight, lactation period, and cotinine concentrations in mother's milk and infant's urine. Toxicol Lett. 1987;35(1):73-81
171. Hopkinson JM, Schanler RJ, Fraley JK, Garza C. Milk production by mothers of premature infants: influence of cigarette smoking. Pediatrics. 1992;90(6):934-938
172. Cobo E. Effect of different doses of ethanol on the milk-ejecting reflex in lactating women. Am J Obstet Gynecol. 1973;115(6): 817-821
173. Little RE, Anderson KW, Ervin CH, Worthington-Roberts B, Clarren SK. Maternal alcohol use during breast-feeding and infant mental and motor development at one year. N Engl J Med. 1989;321(7):425-430
174. Anderson PO. Alcohol and breastfeeding. J Hum Lact. 1995;11(4):321-323
175. Jakubovic A, Tait RM, McGeer PL. Excretion of THC and its metabolites in ewes' milk. Toxicol Appl Pharmacol. 1974;28(1):38-43
176. American Academy of Pediatrics Committee on Drugs. Transfer of drugs and other chemicals into human milk. Pediatrics. 2001;108(3):776-789
177. Gartner LM, Morton J, Lawrence RA, et al; American Academy of Pediatrics Section on Breastfeeding. Breastfeeding and the use of human milk. Pediatrics. 2005;115 (2):496-506
178. Dunn HG, McBurney AK, Ingram S, Hunter CM. Maternal cigarette smoking during pregnancy and the child's subsequent development: I. Physical growth to the age of 6 1/2 years. Can J Public Health. 1976;67(6):499-505
179. Naeye RL. Influence of maternal cigarette smoking during pregnancy on fetal and childhood growth. Obstet Gynecol. 1981;57 (1):18-21
180. Rantakallio P. A follow-up study up to the age of 14 of children whose mothers smoked during pregnancy. Acta Paediatr Scand. 1983;72(5):747-753
181. Fogelman KR, Manor O. Smoking in pregnancy and development into early adulthood. BMJ. 1988;297(6658):1233-1236
182. Day NL, Richardson GA, Geva D, Robles N. Alcohol, marijuana, and tobacco: effects of prenatal exposure on offspring growth and morphology at age six. Alcohol Clin Exp Res. 1994;18(4):786-794
183. Vik T, Jacobsen G, Vatten L, Bakketeig LS. Pre- and post-natal growth in children of women who smoked in pregnancy. Early Hum Dev. 1996;45(3):245-255
184. Fried PA, James DS, Watkinson B. Growth and pubertal milestones during adolescence in offspring prenatally exposed to cigarettes and marihuana. Neurotoxicol Teratol. 2001;23(5):431-436
185. Davies JK, Bledsoe JM. Prenatal alcohol and drug exposures in adoption. Pediatr Clin North Am. 2005;52(5):1369-1393, vii
186. Shankaran S, Lester BM, Das A, et al. Impact of maternal substance use during pregnancy on childhood outcome. Semin Fetal Neonatal Med. 2007;12(2):143-150
187. Hurt H, Brodsky NL, Betancourt L, Braitman LE, Malmud E, Giannetta J. Cocaine-exposed children: follow-up through 30 months. J Dev Behav Pediatr. 1995;16(1):29-35
188. Covington CY, Nordstrom-Klee B, Ager J, Sokol R, Delaney-Black V. Birth to age 7 growth of children prenatally exposed to drugs: a prospective cohort study. Neurotoxicol Teratol. 2002;24(4):489-496
189. Minnes S, Robin NH, Alt AA, et al. Dysmorphic and anthropometric outcomes in 6-year-old prenatally cocaine-exposed children. Neurotoxicol Teratol. 2006;28(1): 28-38
190. Richardson GA, Conroy ML, Day NL. Prenatal cocaine exposure: effects on the development of school-age children. Neurotoxicol Teratol. 1996;18(6):627-634
191. Kilbride H, Castor C, Hoffman E, Fuger KL. Thirty-six-month outcome of prenatal cocaine exposure for term or near-term infants: impact of early case management. J Dev Behav Pediatr. 2000;21(1):19-26
192. Eriksson M, Jonsson B, Steneroth G, Zetterström R. Cross-sectional growth of children whose mothers abused amphetamines during pregnancy. Acta Paediatr. 1994;83(6):612-617
193. Kristjansson EA, Fried PA, Watkinson B. Maternal smoking during pregnancy affects children's vigilance performance. Drug Alcohol Depend. 1989;24(1):11-19
194. Fried PA, Watkinson B, Gray R. A follow-up study of attentional behavior in 6-year-old children exposed prenatally to marihuana, cigarettes, and alcohol. Neurotoxicol Teratol. 1992;14(5):299-311
195. Thapar A, Fowler T, Rice F, et al. Maternal smoking during pregnancy and attention deficit hyperactivity disorder symptoms in offspring. Am J Psychiatry. 2003;160(11): 1985-1989
196. Kotimaa AJ, Moilanen I, Taanila A, et al. Maternal smoking and hyperactivity in 8-year-old children. J Am Acad Child Adolesc Psychiatry. 2003;42(7):826-833
197. Brook JS, Brook DW, Whiteman M. The influence of maternal smoking during pregnancy on the toddler's negativity. Arch Pediatr Adolesc Med. 2000;154(4):381-385
198. Day NL, Richardson GA, Goldschmidt L, Cornelius MD. Effects of prenatal tobacco exposure on preschoolers' behavior. J Dev Behav Pediatr. 2000;21(3):180-188
199. Wakschlag LS, Hans SL. Maternal smoking during pregnancy and conduct problems in high-risk youth: a developmental framework. Dev Psychopathol. 2002;14(2): 351-369
200. Batstra L, Hadders-Algra M, Neeleman J. Effect of antenatal exposure to maternal smoking on behavioural problems and academic achievement in childhood: prospective evidence from a Dutch birth cohort. Early Hum Dev. 2003;75(1-2):21-33
201. Naeye RL. Cognitive and behavioral abnormalities in children whose mothers smoked cigarettes during pregnancy. J Dev Behav Pediatr. 1992;13(6):425-428
202. Fergusson DM, Horwood LJ, Lynskey MT. Maternal smoking before and after pregnancy: effects on behavioral outcomes in middle childhood. Pediatrics. 1993;92(6): 815-822
203. Fergusson DM, Woodward LJ, Horwood LJ. Maternal smoking during pregnancy and psychiatric adjustment in late adolescence. Arch Gen Psychiatry. 1998;55(8): 721-727
204. Williams GM, O'Callaghan M, Najman JM, et al. Maternal cigarette smoking and child psychiatric morbidity: a longitudinal study. Pediatrics. 1998;102(1). Available at: www.pediatrics.org/cgi/content/full/102/1/e11
205. Räsänen P, Hakko H, Isohanni M, Hodgins S, Järvelin MR, Tiihonen J. Maternal smoking during pregnancy and risk of criminal behavior among adult male offspring in the Northern Finland 1966 Birth Cohort. Am J Psychiatry. 1999;156(6):857-862
206. Weissman MM, Warner V, Wickramaratne PJ, Kandel DB. Maternal smoking during pregnancy and psychopathology in offspring followed to adulthood. J Am Acad Child Adolesc Psychiatry. 1999;38(7):892-899
207. Nanson JL, Hiscock M. Attention deficits in children exposed to alcohol prenatally. Alcohol Clin Exp Res. 1990;14(5):656-661
208. Streissguth AP, Sampson PD, Olson HC, et al. Maternal drinking during pregnancy: attention and short-term memory in 14-year-old offspring-a longitudinal prospective study. Alcohol Clin Exp Res. 1994;18(1):202-218
209. Streissguth AP, Bookstein FL, Sampson PD, Barr HM. Attention: prenatal alcohol and continuities of vigilance and attentional problems from 4 through 14 years. Dev Psychopathol. 1995;7(3):419-446
210. Coles CD, Platzman KA, Raskind-Hood CL, Brown RT, Falek A, Smith IE. A comparison of children affected by prenatal alcohol exposure and attention deficit, hyperactivity disorder. Alcohol Clin Exp Res. 1997;21(1):150-161
211. Streissguth AP, Bookstein FL, Barr HM, Sampson PD, O'Malley K, Young JK. Risk factors for adverse life outcomes in fetal alcohol syndrome and fetal alcohol effects. J Dev Behav Pediatr. 2004;25(4): 228-238
212. Kelly SJ, Day N, Streissguth AP. Effects of prenatal alcohol exposure on social behavior in humans and other species. Neurotoxicol Teratol. 2000;22(2):143-149
213. Goldschmidt L, Day NL, Richardson GA. Effects of prenatal marijuana exposure on child behavior problems at age 10. Neurotoxicol Teratol. 2000;22(3):325-336
214. Rosen TS, Johnson HL. Long-term effects of prenatal methadone maintenance. NIDA Res Monogr. 1985;59:73-83
215. Lifschltz MH, Wilson GS. Patterns of growth and development in narcoticexposed children. NIDA Res Monogr. 1991;114:323-339
216. Warner TD, Behnke M, Hou W, Garvan CW, Wobie K, Eyler FD. Predicting caregiverreported behavior problems in cocaineexposed children at 3 years. J Dev Behav Pediatr. 2006;27(2):83-92
217. Accornero VH, Anthony JC, Morrow CE, Xue L, Bandstra ES. Prenatal cocaine exposure: an examination of childhood externalizing and internalizing behavior problems at age 7 years. Epidemiol Psichiatr Soc. 2006;15(1):20-29
218. Linares TJ, Singer LT, Kirchner HL, et al. Mental health outcomes of cocaineexposed children at 6 years of age. J Pediatr Psychol. 2006;31(1):85-97
219. Sood BG, Nordstrom Bailey B, Covington C, et al. Gender and alcohol moderate caregiver reported child behavior after prenatal cocaine. Neurotoxicol Teratol. 2005;27(2):191-201
220. Bendersky M, Bennett D, Lewis M. Aggression at age 5 as a function of prenatal exposure to cocaine, gender, and environmental risk. J Pediatr Psychol. 2006;31 (1):71-84
221. Dennis T, Bendersky M, Ramsay D, Lewis M. Reactivity and regulation in children prenatally exposed to cocaine. Dev Psychol. 2006;42(4):688-697
222. Bada HS, Das A, Bauer CR, et al. Impact of prenatal cocaine exposure on child behavior problems through school age. Pediatrics. 2007;119(2). Available at: www.pediatrics.org/cgi/content/full/119/2/e348
223. Delaney-Black V, Covington C, Templin T, et al. Teacher-assessed behavior of children prenatally exposed to cocaine. Pediatrics. 2000;106(4):782-791
224. Nordstrom Bailey B, Sood BG, Sokol RJ, et al. Gender and alcohol moderate prenatal cocaine effects on teacher-report of child behavior. Neurotoxicol Teratol. 2005;27(2):181-189
225. Eriksson M, Billing L, Steneroth G, Zetterström R. Health and development of 8-year-old children whose mothers abused amphetamine during pregnancy. Acta Paediatr Scand. 1989;78(6):944-949
226. Billing L, Eriksson M, Jonsson B, Steneroth G, Zetterström R. The influence of environmental factors on behavioural problems in 8-year-old children exposed to amphetamine during fetal life. Child Abuse Negl. 1994;18(1):3-9
227. Fried PA, O'Connell CM, Watkinson B. 60- and 72-month follow-up of children prenatally exposed to marijuana, cigarettes, and alcohol: cognitive and language assessment. J Dev Behav Pediatr. 1992;13(6):383-391
228. Cornelius MD, Ryan CM, Day NL, Goldschmidt L, Willford JA. Prenatal tobacco effects on neuropsychological outcomes among preadolescents. J Dev Behav Pediatr. 2001;22(4):217-225
229. Olds DL, Henderson CR, Jr, Tatelbaum R. Intellectual impairment in children of women who smoke cigarettes during pregnancy. Pediatrics. 1994;93(2):221-227
230. Fried PA. Adolescents prenatally exposed to marijuana: examination of facets of complex behaviors and comparisons with the influence of in utero cigarettes. J Clin Pharmacol. 2002;42(suppl 11):97S-102S
231. Fried PA, Watkinson B, Gray R. Differential effects on cognitive functioning in 13- to 16-year-olds prenatally exposed to cigarettes and marihuana. Neurotoxicol Teratol. 2003;25(4):427-436
232. Howell KK, Lynch ME, Platzman KA, Smith GH, Coles CD. Prenatal alcohol exposure and ability, academic achievement, and school functioning in adolescence: a longitudinal follow-up. J Pediatr Psychol. 2006;31(1):116-126
233. Kodituwakku PW, Kalberg W, May PA. The effects of prenatal alcohol exposure on executive functioning. Alcohol Res Health. 2001;25(3):192-198
234. Fried PA, Watkinson B, Gray R. Differential effects on cognitive functioning in 9- to 12-year olds prenatally exposed to cigarettes and marihuana. Neurotoxicol Teratol. 1998;20(3):293-306
235. Fried PA, Smith AM. A literature review of the consequences of prenatal marihuana exposure. An emerging theme of a deficiency in aspects of executive function. Neurotoxicol Teratol. 2001;23(1):1-11
236. Fried PA, Watkinson B. Differential effects on facets of attention in adolescents prenatally exposed to cigarettes and marihuana. Neurotoxicol Teratol. 2001;23 (5):421-430
237. Richardson GA, Ryan C, Willford J, Day NL, Goldschmidt L. Prenatal alcohol and marijuana exposure: effects on neuropsychological outcomes at 10 years. Neurotoxicol Teratol. 2002;24(3):309-320
238. Lifschitz MH, Wilson GS, Smith EO, Desmond MM. Factors affecting head growth and intellectual function in children of drug addicts. Pediatrics. 1985;75(2):269-274
239. Kaltenbach K, Finnegan LP. Children exposed to methadone in utero: assessment of developmental and cognitive ability. Ann N Y Acad Sci. 1989;562:360-362
240. Kaltenbach KA, Finnegan LP. Prenatal narcotic exposure: perinatal and developmental effects. Neurotoxicology. 1989;10(3):597-604
241. Bennett DS, Bendersky M, Lewis M. Children's intellectual and emotional-behavioral adjustment at 4 years as a function of cocaine exposure, maternal characteristics, and environmental risk. Dev Psychol. 2002;38(5):648-658
242. Wasserman GA, Kline JK, Bateman DA, et al. Prenatal cocaine exposure and school-age intelligence. Drug Alcohol Depend. 1998;50(3):203-210
243. Hurt H, Malmud E, Betancourt LM, Brodsky NL, Giannetta JM. A prospective comparison of developmental outcome of children with in utero cocaine exposure and controls using the Battelle Developmental Inventory. J Dev Behav Pediatr. 2001;22(1): 27-34
244. Arendt RE, Short EJ, Singer LT, et al. Children prenatally exposed to cocaine: developmental outcomes and environmental risks at seven years of age. J Dev Behav Pediatr. 2004;25(2):83-90
245. Messinger DS, Bauer CR, Das A, et al. The maternal lifestyle study: cognitive, motor, and behavioral outcomes of cocaineexposed and opiate-exposed infants through three years of age. Pediatrics. 2004;113(6):1677-1685
246. Pulsifer MB, Radonovich K, Belcher HM, Butz AM. Intelligence and school readiness in preschool children with prenatal drug exposure. Child Neuropsychol. 2004;10(2): 89-101
247. Singer LT, Minnes S, Short E, et al. Cognitive outcomes of preschool children with prenatal cocaine exposure. JAMA. 2004;291(20):2448-2456
248. Frank DA, Rose-Jacobs R, Beeghly M, Wilbur M, Bellinger D, Cabral H. Level of prenatal cocaine exposure and 48-month IQ: importance of preschool enrichment. Neurotoxicol Teratol. 2005;27(1):15-28
249. Morrow CE, Culbertson JL, Accornero VH, Xue L, Anthony JC, Bandstra ES. Learning disabilities and intellectual functioning in school-aged children with prenatal cocaine exposure. Dev Neuropsychol. 2006;30(3):905-931
250. Hurt H, Betancourt LM, Malmud EK, et al. Children with and without gestational cocaine exposure: a neurocognitive systems analysis. Neurotoxicol Teratol. 2009;31(6): 334-341
251. Leech SL, Richardson GA, Goldschmidt L, Day NL. Prenatal substance exposure: effects on attention and impulsivity of 6-year-olds. Neurotoxicol Teratol. 1999;21(2):109-118
252. Bandstra ES, Morrow CE, Anthony JC, Accornero VH, Fried PA. Longitudinal investigation of task persistence and sustained attention in children with prenatal cocaine exposure. Neurotoxicol Teratol. 2001;23(6):545-559
253. Savage J, Brodsky NL, Malmud E, Giannetta JM, Hurt H. Attentional functioning and impulse control in cocaineexposed and control children at age ten years. J Dev Behav Pediatr. 2005;26(1):42-47
254. Mayes L, Snyder PJ, Langlois E, Hunter N. Visuospatial working memory in schoolaged children exposed in utero to cocaine. Child Neuropsychol. 2007;13(3):205-218
255. Chang L, Smith LM, LoPresti C, et al. Smaller subcortical volumes and cognitive deficits in children with prenatal methamphetamine exposure. Psychiatry Res. 2004;132(2):95-106
256. Delaney-Black V, Covington C, Templin T, et al. Expressive language development of children exposed to cocaine prenatally: literature review and report of a prospective cohort study. J Commun Disord. 2000;33(6):463-480, quiz 480-481
257. Fried PA, Watkinson B. 36- and 48-month neurobehavioral follow-up of children prenatally exposed to marijuana, cigarettes, and alcohol. J Dev Behav Pediatr. 1990;11(2):49-58
258. Fried PA, Watkinson B, Siegel LS. Reading and language in 9- to 12-year olds prenatally exposed to cigarettes and marijuana. Neurotoxicol Teratol. 1997;19(3):171-183
259. Mattson SN, Riley EP. A review of the neurobehavioral deficits in children with fetal alcohol syndrome or prenatal exposure to alcohol. Alcohol Clin Exp Res. 1998;22(2):279-294
260. Coggins TE, Timler GR, Olswang LB. A state of double jeopardy: impact of prenatal alcohol exposure and adverse environments on the social communicative abilities of school-age children with fetal alcohol spectrum disorder. Lang Speech Hear Serv Sch. 2007;38(2):117-127
261. Bandstra ES, Morrow CE, Vogel AL, et al. Longitudinal influence of prenatal cocaine exposure on child language functioning. Neurotoxicol Teratol. 2002;24(3):297-308
262. Lewis BA, Singer LT, Short EJ, et al. Fouryear language outcomes of children exposed to cocaine in utero. Neurotoxicol Teratol. 2004;26(5):617-627
263. Streissguth AP, Barr HM, Sampson PD. Moderate prenatal alcohol exposure: effects on child IQ and learning problems at age 7 1/2 years. Alcohol Clin Exp Res. 1990;14(5):662-669
264. Coles CD, Brown RT, Smith IE, Platzman KA, Erickson S, Falek A. Effects of prenatal alcohol exposure at school age. I. Physical and cognitive development. Neurotoxicol Teratol. 1991;13(4):357-367
265. Goldschmidt L, Richardson GA, Stoffer DS, Geva D, Day NL. Prenatal alcohol exposure and academic achievement at age six: a nonlinear fit. Alcohol Clin Exp Res. 1996;20(4):763-770
266. Olson HC, Streissguth AP, Sampson PD, Barr HM, Bookstein FL, Thiede K. Association of prenatal alcohol exposure with behavioral and learning problems in early adolescence. J Am Acad Child Adolesc Psychiatry. 1997;36(9):1187-1194
267. Goldschmidt L, Richardson GA, Cornelius MD, Day NL. Prenatal marijuana and alcohol exposure and academic achievement at age 10. Neurotoxicol Teratol. 2004;26(4):521-532
268. Levine TP, Liu J, Das A, et al. Effects of prenatal cocaine exposure on special education in school-aged children. Pediatrics. 2008;122(1). Available at: www.pediatrics.org/cgi/content/full/122/1/e83
269. Hurt H, Brodsky NL, Roth H, Malmud E, Giannetta JM. School performance of children with gestational cocaine exposure. Neurotoxicol Teratol. 2005;27(2):203-211
270. Cernerud L, Eriksson M, Jonsson B, Steneroth G, Zetterström R. Amphetamine addiction during pregnancy: 14-year follow-up of growth and school performance. Acta Paediatr. 1996;85(2):204-208
271. Cornelius MD, Leech SL, Goldschmidt L, Day NL. Prenatal tobacco exposure: is it a risk factor for early tobacco experimentation? Nicotine Tob Res. 2000;2(1):45-52
272. Buka SL, Shenassa ED, Niaura R. Elevated risk of tobacco dependence among offspring of mothers who smoked during pregnancy: a 30-year prospective study. Am J Psychiatry. 2003;160(11):1978-1984
273. Porath AJ, Fried PA. Effects of prenatal cigarette and marijuana exposure on drug use among offspring. Neurotoxicol Teratol. 2005;27(2):267-277
274. Brennan PA, Grekin ER, Mortensen EL, Mednick SA. Relationship of maternal smoking during pregnancy with criminal arrest and hospitalization for substance abuse in male and female adult offspring. Am J Psychiatry. 2002;159(1):48-54
275. Baer JS, Barr HM, Bookstein FL, Sampson PD, Streissguth AP. Prenatal alcohol exposure and family history of alcoholism in the etiology of adolescent alcohol problems. J Stud Alcohol. 1998;59(5):533-543
276. Yates WR, Cadoret RJ, Troughton EP, Stewart M, Giunta TS. Effect of fetal alcohol exposure on adult symptoms of nicotine, alcohol, and drug dependence. Alcohol Clin Exp Res. 1998;22(4):914-920
277. Alati R, Al Mamun A, Williams GM, O'Callaghan M, Najman JM, Bor W. In utero alcohol exposure and prediction of alcohol disorders in early adulthood: a birth cohort study. Arch Gen Psychiatry. 2006;63 (9):1009-1016